Add-on Reparixin in Adult Patients With ARDS

Clinical trial NCT05496868 · COMPLETED

Trial details

NCT number: NCT05496868
Sponsor: Dompé Farmaceutici S.p.A
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome, Adult

Start date: 2022-12-06
Primary completion: 2025-03-18
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.